In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side ...
A new RAND report shows nearly 12% of U.S. adults now use GLP-1 drugs like Ozempic and Wegovy, and it’s changing how they shop. Food companies say the biggest shift isn’t in portion sizes but in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback